Kulda Vlastimil, Pesta Martin, Topolcan Ondrej, Liska Vaclav, Treska Vladislav, Sutnar Alan, Rupert Karel, Ludvikova Marie, Babuska Vaclav, Holubec Lubos, Cerny Radim
Department of Biochemistry, Faculty of Medicine in Pilsen, Charles University in Prague, Czech Republic.
Cancer Genet Cytogenet. 2010 Jul 15;200(2):154-60. doi: 10.1016/j.cancergencyto.2010.04.015.
MicroRNAs, which are endogenously expressed regulatory noncoding RNAs, have an altered expression in colorectal cancer. The aim of our study was to assess the relationship of miR-21 and miR-143 expression to the prognostic/clinicopathological features of colorectal carcinoma (CRC) and colorectal liver metastases (CLM). The estimation was performed in 46 paired (tumor and control) tissue samples of CRC. Further, we studied 30 tissue samples of CLM. MiR-21 and miR-143 expressions were quantified by using the quantitative reverse transcription polymerase chain reaction method. Relation of miR-21 and miR-143 expression to disease-free interval (DFI) (Wilcoxon; P = 0.0026 and P = 0.0191, respectively) was recorded. There was shorter DFI in patients with a higher expression of miR-21 and, surprisingly, also in patients with a higher expression of miR-143, which is a putative tumor suppressor. There was a higher expression of miR-21 and lower expression of miR-143 in CRC tissue in comparison with adjacent normal colon tissue (P < 0.0001; P < 0.0001, respectively). Similarly, we observed a higher expression of miR-21 and a lower expression of miR-143 in CLM in comparison with normal colon tissue (P < 0.0001; P < 0.0001, respectively). Our results support the hypothesis about oncogenic function of miR-21 and show its relation to DFI. The role of miR-143 in carcinogenesis seems to be more complex.
微小RNA是内源性表达的调控性非编码RNA,在结直肠癌中表达发生改变。我们研究的目的是评估miR-21和miR-143表达与结直肠癌(CRC)及结直肠癌肝转移(CLM)的预后/临床病理特征之间的关系。对46对(肿瘤和对照)CRC组织样本进行了评估。此外,我们研究了30例CLM组织样本。采用定量逆转录聚合酶链反应法对miR-21和miR-143的表达进行定量。记录了miR-21和miR-143表达与无病生存期(DFI)的关系(Wilcoxon检验;P值分别为0.0026和0.0191)。miR-21高表达的患者以及令人惊讶的是miR-143高表达的患者(miR-143是一种假定的肿瘤抑制因子)的DFI较短。与相邻正常结肠组织相比,CRC组织中miR-21表达较高而miR-143表达较低(P均<0.0001)。同样,与正常结肠组织相比,我们在CLM中观察到miR-21表达较高而miR-143表达较低(P均<0.0001)。我们的结果支持关于miR-21致癌功能的假说,并表明其与DFI有关。miR-143在致癌过程中的作用似乎更为复杂。